December 2024 ZOHU Call/Webinar

What to know

A video recording of this webinar is posted below. Visit CDC TRAIN to get free continuing education (CE) for this webinar.

1 hour

Dec 4, 2024

Webinar details

Presentation topics

  • An Overview of Highly Pathogenic Avian Influenza (HPAI) in Dairy Cattle
  • Public Health Data Applications Using the CDC Tracking Network: Augmenting Environmental Hazard Information with Lower‐Latency NASA Data

Watch the webinar

Featuring

Jason Lombard, DVM MS | Presenter
Veterinary Epidemiologist
College of Veterinary Medicine and Biomedical Sciences, Colorado State University
Angela Werner, PhD, MPH | Presenter
Lead Health Scientist (Data Scientist)
NCEH Tracking Program Science Development Team Lead, National Center for Environmental Health, Centers for Disease Control and Prevention
Stephanie Schollaert Uz, PhD | Presenter
Applied Sciences Manager
Earth Sciences Division, NASA Goddard Space Flight Center
Helen Amos, PhD | Presenter
Applications Scientist (former) Science Systems and Applications, Inc. (SSA) contractor supporting
Earth Sciences Division, Applied Sciences, NASA Goddard Space Flight Center

Continuing Education (CE)

Visit CDC Train to receive continuing education (CE).

Webcast (Live)

  • Course Name: WC4565R-120424
  • Registration Code: ZOHUwebcast
  • Start Date: December 4, 2024
  • End Date: January 6, 2025

Web-on-Demand (Recording)

  • Course Name: WD4565R-120424
  • Start Date: January 7, 2025
  • End Date: January 7, 2027

Series Objectives

1. Identify an implication for human, animal, and environmental health.

2. Identify a One Health approach strategy for prevention of public health threats.

3. Identify a One Health approach strategy for detection of public health threats.

4. Identify a One Health approach strategy for responding to public health threats.

5. List two ways to improve collaborative practice across the public healthcare team.

Disclosures

In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies over the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.

CDC, our planners, and presenters wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Content will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC did not accept commercial or in-kind support for this activity.